Browsing Tag
FDA Phase 3 clearance
1 post
Advanced melanoma immunotherapy enters a new phase as Scancell secures Phase 3 clearance
Scancell Holdings Plc, iSCIB1+, advanced melanoma, melanoma immunotherapy, FDA Phase 3 clearance, cancer vaccines, ImmunoBody platform